A Mathematical Model of Atherosclerosis with Reverse Cholesterol Transport and Associated Risk Factors

Bulletin of Mathematical Biology

Volumn 77, Issue 5, 2015, Pages 758-781

  Friedman, Avner ^a   Hao, Wenrui ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Free boundary; Math modeling; Plaque formation; Reverse cholesterol transport

Indexed keywords

MUS;

CHOLESTEROL;

ACTIVE TRANSPORT; ANIMAL; ATHEROSCLEROSIS; BIOLOGICAL MODEL; HUMAN; MATHEMATICAL PHENOMENA; METABOLISM; MOUSE; PERSONALIZED MEDICINE; RISK FACTOR;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT, ACTIVE; CHOLESTEROL; HUMANS; MATHEMATICAL CONCEPTS; MICE; MODELS, CARDIOVASCULAR; PRECISION MEDICINE; RISK FACTORS;

EID: 84930678791     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-014-0010-3     Document Type: Article

References (59)

1. Alexander ET, Weibel GL, Joshi MR, Vedhachalam C, de la Llera-Moya M, Rothblat GH, Phillips MC, Rader DJ (2009) Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano. Arterioscler Thromb Vasc Biol. 29(10):1496–501
2. Ambrose JA, Barua R (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. Am Coll Cardiol 43:1731–1737
3. American Heart Association (2013) Heart and artery damage and high blood pressure. http://www.heart.org/Heart-and-Artery-Damage-and-High-Blood-Pressure-UCM-301823-Article.jsp
4. Arsenault B, Rana J, Stroes S, Despres P, Shah P (2009) Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol 55:35–41
5. Azzam KM, Fessler MB (2012) Crosstalk between reverse cholesterol transport and innate immunity. Trends Endocrinol Metab 23(4):169–178
6. Barter P (2005) The role of HDL-cholesterol in preventing atherosclerotic disease. Eur Heart J Suppl 7:4–8
7. Cadenas E, Davies K (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29:222–230
8. Calvez V, Ebde A, Meunier N, Raoult A (2009) Mathematical modelling of the atherosclerotic plaque formation. CEMRACS 2008 Modell Numer Simul Complex Fluids 28:1–12
9. Chen WJ, Zhang M, Zhao GJ, Fu Y, Zhang DW, Zhu HB, Tang CK (2013) MicroRNA-33 in atherosclerosis etiology and pathophysiology. Atherosclerosis 227(2):201–8
10. Cimen M (2008) Free radical metabolism in human erythrocytes. Clin Chim Acta 390:1–11
11. Cohen A, Myerscough M, Thompson R (2012) Athero-protective effects of high density lipoproteins (HDL): an ODE model of the early stages of atherosclerosis, preprint
12. Cuchel M, Rader DJ (2006) Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation 113(21):2548–2555
13. Cucuianu M, Coca M, Hancu N (2007) Reverse cholesterol transport and atherosclerosis. A mini review. Rom J Intern Med 45(1):17–27
14. Cynshi O, Kawabe Y, Tsukasa N (1998) Antiatherogenic effects of the antioxidant BO-653 in three different animal models Osamu. Proc Natl Acad Sci USA 95(17):10123–10128
15. Deepa T, Binu L, Sukesh A (2009) Modelling blood flow and analysis of atherosclerotic plaque rupture under G-force. Bioinform Biomed 23:1–4
16. de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Cuchel M, Rader DJ, Rothblat GH (2010) The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler Thromb Vasc Biol 30(4):796–801
17. Fabunmi R, Sukhova G, Sugiyama S, Libby P (1998) Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells a potential protective mechanism in plaque stability. Circ Res 83:270–278
18. Feig JE, Parathath S, Rong JX, Mick SL, Vengrenyuk Y, Grauer L, Young SG, Fisher EA (2011a) Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation 123(9):989–998
19. Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, Liu J, Rayner K, Moore K, Garabedian M, Fisher EA (2011b) HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc Natl Acad Sci 108(17):7166–7171
20. Francis AA, Pierce GN (2011) An integrated approach for the mechanisms responsible for atherosclerotic plaque regression. Exp Clin Cardiol 16(3):77C86
21. Gui T, Shimokado A, Sun Y, Akasaka T, Muragaki Y (2012) Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery. Mediat Inflamm 2012:693083
22. Hansson G, Holm J, Jonasson L (1983) Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 135:169–175
23. Hao W, Friedman A (2014) The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model. Plos One e90497
24. Harrington J (2000) The role of MCP-1 in atherosclerosis. Stem Cells 18:65–66
25. He B, Zhao S, Peng Z (2013) Effects of cigarette smoking on HDL quantity and function: implications for atherosclerosis. J Cell Biochem 114:2431–2436
26. Hoyert D, Xu J (2012) Deaths: preliminary data for 2011. National vital statistics reports 61
27. http://www.health.am/ (2004) What are LDL cholesterol particle size patterns A and B?
28. Hu YW, Hu YR, Zhao JY, Li SF, Ma X, Wu SG, Lu JB, Qiu YR, Sha YH, Wang YC, Gao JJ, Zheng L, Wang Q (2014) An agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production. PLoS One 9(4):e94997
29. Johnson J, Newby A (2009) Macrophage heterogeneity in atherosclerotic plaques. Curr Opin Lipidol 20:370–378
30. King I, Segal B (2005) Cutting edge: IL-12 induces CD4+CD25- T cell activation in the presence of T regulatory cells. J Immunol 175:641–645
31. Kosaka C, Masuda J, Shimokado K, Zen K, Yokota T, Sasaguri T, Ogata J (1992) Interferon-gamma suppresses PDGF production from THP-1 cells and blood monocyte-derived macrophages. Atherosclerosis 97:75–87
32. Little M, Gola A, Tzoulaki I (2009) A model of cardiovascular disease giving a plausible mechanism for the effect of fractionated low-dose Ionizing radiation exposure. PLoS Computat Biol 5:e1000539
33. Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta N, Steer BM, Ingram AJ, Gupta M, Al-Omran M, Teoh H, Marsden PA, Verma S (2012) MicroRNA-145 targeted therapy reduces atherosclerosis. Circulation 126(11 Suppl 1):S81–90
34. McKay C, McKee S, Mottram N, Mulholland T Wilson S (2005) Towards a model of atherosclerosis. Strathclyde Mathematics Research Report
35. Moore KJ, Sheedy FJ, Fisher EA (2013) Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 13(10):709–721
36. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106:3143–3421
37. Neufeld E, Mietus-Snyder M, Beiser A, Baker A, Newburger J (1997) Passive cigarette smoking and reduced HDL cholesterol levels in children with high-risk lipid profiles. Circulation 96:1403–1407
38. Noguchi N, Niki E (1998) Dynamics of vitamin E action against LDL oxidation. Free Radic Res 28(6):561–572
39. Osterud B, Bjorklid E (2003) Role of monocytes in atherogenesis. Physiol Rev 83:1069–1112
40. Panousis CG, Evans G, Zuckerman SH (2011) TGF-beta increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: opposing the effects of IFN-gamma. J Lipid Res 42(5):856–863
41. Pencina M, Navar-Boggan M, D’Agostino R (2014) Application of new cholesterol guidelines to a population-based sample. N Engl J Med
42. Powell J (1998) Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med 3:21–28
43. Raines E, Ross R (1993) Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 69:30–37
44. Ralph P, Sacco L, Benjamin E (1997) Risk factors. Stroke 28:1507–1517
45. Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y, Fernandez-Hernando C, Fisher EA, Moore KJ (2011) Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest 121(7):2921–2931
46. Reape T, Groot P (1999) Chemokines and atherosclerosis. Atherosclerosis 147:213–225
47. Rodriguez J, Orbe J, Paramo J (2007) Metalloproteases, vascular remodeling, and atherothrombotic syndromes. Rev Esp Cardiol 60:959–967
48. Ross R, Masuda J, Raines E, Gown A, Katsuda S, Sasahara M, Malden L, Masuko H, Sato H (1990) Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 248:1009–1012
49. Ryu B (2000) Low density lipoprotein (LDL), atherosclerosis and antioxidants. Biotechnol Bioprocess Eng 5:313–319
50. Sanson M, Distel E, Fisher EA (2013) HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process. PLoS One 8(8):e74676
51. Schiopu A, Frendeus B, Jansson B, Soderberg I, Ljungcrantz I, Araya Z, Shah PK, Carlsson R, Nilsson J, Fredrikson GN (2007) Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice. J Am Coll Cardiol 50(24):2313–2318
52. Stone N, Robinson J, Lichtenstein H, Bairey M, Lloyd-Jones D (2013) 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol
53. Tall AR, Wang N, Mucksavage P (2001) Is it time to modify the reverse cholesterol transport model? J Clin Invest 108(9):1273–1275
54. The top 10 causes of death. http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed Dec 18, 2013
55. Vikstedt R, Metso J, Hakala J, Olkkonen VM, Ehnholm C, Jauhiainen M (2007) Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles. Biochemistry 46(42):11979–11986
56. Wang MD, Franklin V, Marcel YL (2007a) In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired. Arterioscler Thromb Vasc Biol 27(8):1837–1842
57. Wang X, Collins HL, Ranalletta M, Fuki IV, Billheimer JT, Rothblat GH, Tall AR, Rader DJ (2007b) Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest 117(8):2216–2224
58. Zhang S, Ritter L, Ibragimov A (2013) Foam cell formation in atherosclerosis: HDL and macrophage reverse cholesterol transport. Discrete Contin Dyn Syst 825–835
59. Zhou X, He W, Huang Z, Gotto AM Jr, Hajjar DP, Han J (2008) Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism. J Biol Chem 283(4):2129–2138